The human platelet receptors for normal, nonimmune IgG and its F(ab')2 and Fc fragments were studied by the use of a cleavable, bifunctional, photoactivable, 125I. '2sI-labeled portion becomes associated with the receptor half of the cross-linked ligand-receptor complex, was utilized to directly identify receptors for the various immunoglobulin ligands. Specificity of the binding reaction could be demonstrated by suppressing the iodination of the receptors with excess nonderivatized ligand. Two principal IgG-related receptors could be identified by high-resolution NaDodSO4/ PAGE and subsequent analysis of the electrophoretically transferred peptides to nitrocellulose filters for localization of radioactivity and immunological characterization. Intact monomeric IgG and F(ab')2 fragments derived from it appeared to have the glycoprotein ia as the major receptor, whereas Fc fragments bound predominantly to a peptide of Mr w200,0OO (Mr, =509000 under rigorous reducing conditions).
(Mr, =509000 under rigorous reducing conditions).
The presence of IgG receptors on human platelets has been shown (1, 2) . Experiments in this laboratory (2) implied that F(ab')2 bound to glycoprotein IIIa, whereas experiments by Rosenfeld et al. (1) showed Fc bound to a 40-kDa peptide. In the latter studies indirect evidence for the binding of the Fc fragment was obtained with monoclonal antibodies, whereas in the former studies IgG derivatives were directly crosslinked to human platelets followed by identification of the cross-linked receptor-ligand complex. We now report the use ofthe 1251I-labeled, bifunctional, cleavable cross-linking agent N-[4-(p-azido-m-[1251]iodophenylazo)benzoyl]-3-aminopropyl-N'-oxysuccinimide ester (Denny-Jaffe reagent, New England Nuclear) (3, 4) to characterize the binding sites for Fc and F(ab')2 normal human IgG fragments and compare these binding results with those obtained using intact IgG (2) .
The techniques that have been successful with small molecular weight hormones (5) are difficult to apply to large ligands. Therefore, to directly demonstrate binding, IgG and IgG fragments were conjugated with a cross-linking agent. The success of such studies depends on the derivatized ligand behaving like the native molecule.
The present studies show similar glycoprotein IIIa binding activity for derivatized and normal IgG or for its F(ab')2 fragments, whereas normal or derivatized Fc fragments were bound to a high molecular weight platelet protein (Mr, =200,000). Binding specificity of derivatized IgG and its fragments was verified because nonderivatized IgG, F(ab')2, or Fc inhibited binding of labeled compounds. All of our present studies were performed exclusively with monomeric IgG.
METHODS AND MATERIALS Preparation of Platelets. Platelets were isolated from acid citrate/dextrose (pH 5.1) (ACD; ref. 20 ) anticoagulated blood (6) . After careful removal of contaminating erythrocytes, platelets were sedimented, and the resulting pellets were resuspended in 0.015 M sodium phosphate (pH 7.2) containing 0.14 M NaCl (PBS) and 15 vol% ACD (final pH, pH 6.0) (6) . To optimize dissociation of platelet-bound IgG, the platelets were allowed to sit at room temperature for 30 min (7) . The platelets were again sedimented by centrifugation and then resuspended in PBS. The final cell concentration was adjusted to 2 x 109 platelets per ml.
Derivatization of IgG and Its Fragments F(ab')2 and Fc with the Denny-Jaffe Reagent. Human IgG from a commercial source and IgG isolated from freshly collected, normal human plasma (2) was dissolved in 0.2 M sodium borate (pH 8.5), pooled to a final concentration of 20 mg/ml, and centrifuged at 100,000 x g for 60 min. The content of the upper half of the centrifugation tube was removed. To document the monomeric nature of the IgG, one portion of this fraction was further analyzed in an analytical ultracentrifuge. A single peak sedimenting with an S20,w of 7.1 was observed. Purity of the IgG was ascertained by immunoelectrophoresis and by NaDodSO4/PAGE under conditions of complete reduction and alkylation. Protein concentrations were determined by the method of Lowry et al. (8) 12, 400) . The gels were either stained by the silver-staining method (11) or electrophoretically transferred onto nitrocellulose filters according to Towbin et al. (12) . The efficiency of the blotting procedure was periodically checked. High molecular weight proteins (Mr, >100,000) showed a moderate decrease of transfer to nitrocellulose. The transfer efficiency varied between 80% and 90%. To evaluate the distribution of radioactivity, the nitrocellulose blots were cut into 2-mm wide sections, and radioactivity was measured in a y counter (counting efficiency for 1251I was .80%). Blotted peptide bands were identified with IgG antibodies having specificity for both heavy and light chains and with antibodies to lithium diiodosalicylateextracted platelet membrane proteins. Procedural details of these methods have been published (2) .
Measurement of Platelet-Associated IgG. The amount of normal or derivatized IgG, F(ab')2, and Fc fragments bound to platelets was measured by the use of fluorescein isothiocyanate-conjugated goat anti-human IgG serum. Details of the method have been described (7) .
Materials. Platelets were isolated from freshly donated The ligands conjugated with cross-linking agent were analyzed by NaDodSO4/PAGE (Figs. 1-3 ). Under conditions of reduction and alkylation, the derivatized immunoglobulin and immunoglobulin fragments yielded the expected pattern of polypeptides. F(ab')2 was incompletely reduced under the experimental conditions used, separating primarily into Fab fragments. Only with very high concentrations of DL-dithiothreitol or 2-mercaptoethanol could complete reduction of Fab be achieved. Each major polypeptide band was still able to react with a polyclonal anti-IgG antibody after electrophoretic transfer to nitrocellulose. In addition to the immunoblot bands associated with the major radioactive peaks, several other bands reacted with anti-IgG antibody. These most likely represent incompletely reduced IgG fragments. The pattern of radioactivity showed fairly equal distribution ofthe cross-linking agent among the various reduced portions of the three immunoglobulin ligands.
Cross-linking of intact IgG to normal human platelets produced two major peaks of radioactivity that corresponded to those seen with reduced IgG conjugated with Denny-Jaffe reagent (Fig. 4) . Other than a relatively small number of counts remaining at or near the interface of stacking and running gel, several peaks of radioactivity were found in the Mr 60,000-115,000 range. Labeling was inhibited by excess unlabeled normal IgG in only the Mr 110,000-115,000 peak (Fig. 4B) . The antiserum against lithium diiodosalicylateextracted platelet membrane proteins bound to this peptide. Studies with F(ab')2 produced similar results (Fig. 5) . Labeled Fc fragments, however, bound to only a single high molecular weight peptide with an estimated Mr -200,000 (Fig. 6) , and excess normal Fc fragments inhibited labeling of this peptide (Fig. 6B) . Under more rigorous reducing conditions (2% 2-mercaptoethanol), this high molecular weight peptide dissociated into monomers of Mr S50,000. With both IgG fragments the major peaks of radioactivity were those expected of free ligand. NaDodSO4/polyacrylamide gradient gels. Protein was reduced with 40 mM dithiothreitol prior to electrophoresis. After the electrophoretic separation, the peptides were immediately blotted onto nitrocellulose. One aliquot of each sample was used for the immunologic identification of the peptides, whereas the other was divided into sequential segments for the determination of radioactivity. Cross-hatched areas represent peptides that reacted with anti-human IgG having both heavy and light chain specificity. To avoid overcrowding with experimental data, some points have been omitted from the graph. However, the solid line traces the exact distribution of counts along the full length of the gel. The arrow indicates the start of the running gel. reliability of identification. Use of this cross-linking agent, however, does not resolve the identification problem completely as the individual radioactive peaks represent either unbound ligands and their components produced by complete reduction or receptors labeled by ligand cross-linking and subsequent cross-link cleavage. Therefore, potential ambiguity remains. We determined the identity of the individual radioactive peaks by the immunoblot technique using selected antibodies whose presence could be shown at high sensitivity with gold-conjugated protein A or with a glucose oxidase-antiglucose oxidase system. With these techniques and by comparing the electrophoretic patterns of radioactive peptides of the original derivatized ligands with the distribution of peptides derived from platelets cross-linked with derivatized IgG or IgO fragments, we were able to determine the identity of virtually all the major radioactive peaks. In this study we again observed that glycoprotein Illa was the receptor for intact IgG confirming the result obtained with a different cross-linking agent (2) .
It was interesting to note that F(ab')2 fragments not only were bound to platelets but appeared to bind to the same receptor glycoprotein IIIa. Fc fragments, on the other hand, were bound to a high molecular weight protein, clearly different from glycoprotein IIIa. The estimated molecular with 125I-labeled cross-linking agent (A). Cross-linked complexes that formed during photoactivation were cleaved by treatment with dithionite prior to electrophoresis. The wide arrow in A indicates the peptide whose i25j labeling could be suppressed by addition of an excess (10 AM) of underivatized F(ab')2. The profile of radioactivity of platelets exposed to a 10-fold excess of normal F(ab')2 is shown inB. Conditions ofexperimental analysis and presentation ofdata are described in Fig. 1 . The thin arrows show the position of the interface between running and stacking gel.
weight (Mr, -200,000 or Mr, =50,000 under rigorous reducing conditions) of this protein is very similar to that described for the nonspecific IgG binding site in platelet immunoblots (14) and is also similar to that described by Cheng increases with the age ofthe cells, and the binding of platelets to macrophages is related to the amount of IgG carrined on the platelet surface (19) . At this time we have no firm data to suggest the fiature of the senescence antigen; however, an alteration in the conformation of glycoprotein flIa, possibly resulting from repeated agonistic stimulation during the life span ofthe platelet yet insufficient to cause removal of the platelet through irreversible aggregation, may be an explanation.
